Dogwood Therapeutics

DWTX

Market cap $58.2M

DWTX Hedge Fund Activity: Q1 2026 in Review

13 of the 8,141 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2026, worth a combined $7.64M — up 2,516% from $292K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DWTX positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $9.65M. The largest seller was Bank of America, exiting entirely with an estimated $39.2K sold.

• 13 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2026, up from 10 in Q4 2025.
• Funds reported $7.64M of Dogwood Therapeutics stock for Q1 2026, up 2,516% quarter-over-quarter.
• 6 funds opened new Dogwood Therapeutics positions in Q1 2026 and 2 closed out, a net change of +4 holders.
• The largest Dogwood Therapeutics buyer in Q1 2026 was Armistice Capital, an estimated $9.65M added.
• The largest Dogwood Therapeutics seller in Q1 2026 was Bank of America, an estimated $39.2K sold.

Based on aggregated 13F filings for Q1 2026.